日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ARF6 as a Novel Activator of HIF-2α in Pulmonary Arterial Hypertension.

ARF6 作为肺动脉高压中 HIF-2α 的新型激活剂

Fellows Adam L, Chen Chien-Nien, Xie Chongyang, Iyer Nayana, Schmidt Lukas, Yin Xiaoke, Yates Luke A, Mayr Manuel, Cowburn Andrew, Zhao Lan, Wojciak-Stothard Beata

Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling

利拉鲁肽早期用于治疗急性 COVID-19 感染:一项开放标签单中心 II 期安全性研究及生物标志物分析

Ferreira, Eloara V M; Oliveira, Rudolf K F; Salomao, Reinaldo; Brunialti, Milena K C; Cardoso, Martyella B A; Chen, Chien-Nien; Zhao, Lan; McCabe, Colm

Deep phenotyping the right ventricle to establish translational MRI biomarkers for characterization of adaptive and maladaptive states in pulmonary hypertension

对右心室进行深度表型分析,以建立转化型磁共振成像生物标志物,用于表征肺动脉高压的适应性和适应不良状态。

Baxan, Nicoleta; Zhao, Lin; Ashek, Ali; Niglas, Marili; Wang, Dingyi; Khassafi, Fatemeh; Sabrin, Farah; Dubois, Olivier; Chen, Chien-Nien; Pullamsetti, Soni Savai; Wilkins, Martin; Zhao, Lan

TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertension

TLR7/8激活可诱发自身免疫性血管病变,并导致严重的肺动脉高压。

Yeh, Fu-Chiang; Chen, Chien-Nien; Xie, Chong-Yang; Baxan, Nicoleta; Zhao, Lin; Ashek, Ali; Sabrin, Farah; Lawrie, Allan; Wilkins, Martin; Zhao, Lan

CLIC4/Arf6 Pathway

CLIC4/Arf6通路

Vahitha B Abdul-Salam ,Giusy Russomanno ,Chen Chien-Nien ,Abdul S Mahomed ,Luke A Yates ,Martin R Wilkins ,Lan Zhao ,Magdalena Gierula ,Oliver Dubois ,Ute Schaeper ,Jens Endruschat ,Beata Wojciak-Stothard

Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid

组蛋白去乙酰化抑制在肺动脉高压中的应用:丙戊酸和辛酰苯胺异羟肟酸的治疗潜力

Zhao, Lan; Chen, Chien-Nien; Hajji, Nabil; Oliver, Eduardo; Cotroneo, Emanuele; Wharton, John; Wang, Daren; Li, Min; McKinsey, Timothy A; Stenmark, Kurt R; Wilkins, Martin R